The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy

Experimental & Molecular Medicine ◽

10.3858/emm.2009.41.11.086 ◽

2009 ◽

Vol 41 (11) ◽

pp. 802 ◽

Cited By ~ 22

Author(s):

Se-Jung Yoon ◽

Young Won Yoon ◽

Byoung Kwon Lee ◽

Hyuck Moon Kwon ◽

Ki-Chul Hwang ◽

...

Keyword(s):

Oxidative Stress ◽

Reductase Inhibitor ◽

Potential Role ◽

Advanced Glycation Endproducts ◽

Advanced Glycation ◽

Glycation Endproducts ◽

Diabetic Vasculopathy ◽

Combined treatment of angiotensin receptor blocker and HMG-CoA reductase inhibitor synergistically improves cardiac dysfunction in Dahl rats

Journal of Molecular and Cellular Cardiology ◽

10.1016/j.yjmcc.2007.07.050 ◽

2008 ◽

Vol 44 (2) ◽

pp. 446-447

Author(s):

Yasuhiro Maejima ◽

Susumu Adachi ◽

Kazuya Isobe ◽

Hiroshi Ito ◽

Mitsuaki Isobe

Keyword(s):

Cardiac Dysfunction ◽

Reductase Inhibitor ◽

Angiotensin Receptor Blocker ◽

Combined Treatment ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hmg Coa Reductase ◽

The HMG-CoA Reductase Inhibitor Cerivastatin Lowers Advanced Glycation End Products in Patients with Type 2 Diabetes

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-2007-973830 ◽

2007 ◽

Vol 115 (06) ◽

pp. 372-375 ◽

Cited By ~ 9

Author(s):

H. Scharnagl ◽

T. Stojakovic ◽

K. Winkler ◽

S. Rosinger ◽

W. März ◽

...

Keyword(s):

Type 2 Diabetes ◽

Advanced Glycation End Products ◽

Reductase Inhibitor ◽

Advanced Glycation ◽

Hmg Coa Reductase ◽

Glycation End Products ◽

End Products ◽

Effects of an HMG-CoA Reductase Inhibitor in Combination with an ACE Inhibitor or Angiotensin II Type 1 Receptor Antagonist on Myocardial Metabolism in Ischemic Rabbit Hearts

Hypertension Research ◽

10.1291/hypres.25.203 ◽

2002 ◽

Vol 25 (2) ◽

pp. 203-210 ◽

Cited By ~ 2

Author(s):

Hitoshi KAWABATA ◽

Kizuku NAKAGAWA ◽

Kinji ISHIKAWA

Keyword(s):

Angiotensin Ii ◽

Receptor Antagonist ◽

Reductase Inhibitor ◽

Ace Inhibitor ◽

Myocardial Metabolism ◽

Hmg Coa Reductase ◽

The HMG-CoA Reductase Inhibitor Lovastatin Reverses the Learning and Attention Deficits in a Mouse Model of Neurofibromatosis Type 1

Current Biology ◽

10.1016/j.cub.2005.09.043 ◽

2005 ◽

Vol 15 (21) ◽

pp. 1961-1967 ◽

Cited By ~ 253

Author(s):

Weidong Li ◽

Yijun Cui ◽

Steven A. Kushner ◽

Robert A.M. Brown ◽

J. David Jentsch ◽

...

Keyword(s):

Mouse Model ◽

Neurofibromatosis Type 1 ◽

Reductase Inhibitor ◽

Neurofibromatosis Type ◽

Attention Deficits ◽

Hmg Coa Reductase ◽

The HMG-CoA reductase inhibitor, simvastatin, has anti-tumorigenic effects in ovarian cancer cell lines and a genetically engineered serous ovarian cancer mouse model

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.149 ◽

2015 ◽

Vol 137 ◽

pp. 63-64

Author(s):

J.E. Stine ◽

X. Han ◽

M. Schointuch ◽

C. Zhou ◽

T. Gilliam ◽

...

Keyword(s):

Ovarian Cancer ◽

Mouse Model ◽

Cell Lines ◽

Reductase Inhibitor ◽

Ovarian Cancer Cell ◽

Genetically Engineered ◽

Serous Ovarian Cancer ◽

Ovarian Cancer Cell Lines ◽

Effect of Combined Treatment With an Angiotensin II Receptor Antagonist and an HMG-CoA Reductase Inhibitor on Atherosclerosis in Genetically Hyperlipidemic Rabbits

Journal of Cardiovascular Pharmacology ◽

10.1097/01.fjc.0000179434.18750.28 ◽

2005 ◽

Vol 46 (4) ◽

pp. 556-562 ◽

Cited By ~ 16

Author(s):

Mikio Kato ◽

Toshio Sada ◽

Makoto Mizuno ◽

Ken Kitayama ◽

Toshimori Inaba ◽

...

Keyword(s):

Angiotensin Ii ◽

Receptor Antagonist ◽

Reductase Inhibitor ◽

Combined Treatment ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Hmg Coa Reductase ◽

Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfl810 ◽

2007 ◽

Vol 22 (4) ◽

pp. 1062-1069 ◽

Cited By ~ 31

Author(s):

M.-L. Koepke ◽

M. Weber ◽

E. Schulze-Lohoff ◽

B. Beirowski ◽

S. Segerer ◽

...

Keyword(s):

Mouse Model ◽

Renal Fibrosis ◽

Alport Syndrome ◽

Reductase Inhibitor ◽

Hmg Coa Reductase ◽

Coa Reductase ◽

Nephroprotective Effect

HMG-CoA reductase inhibitor, rosuvastatin averted carbon tetrachloride-induced oxidative stress, inflammation and fibrosis in the liver of rats

Journal of Advanced Biotechnology and Experimental Therapeutics ◽

10.5455/jabet.2020.d101 ◽

2020 ◽

Vol 3 (1) ◽

pp. 01

Author(s):

Biswajit Sikder ◽

Farzana Akter ◽

Anayt Ulla ◽

Nusrat Subhan ◽

Iqbal Ahmed ◽

...

Keyword(s):

Oxidative Stress ◽

Carbon Tetrachloride ◽

Reductase Inhibitor ◽

Hmg Coa Reductase ◽

Combined Treatment of HMG-CoA Reductase Inhibitor and Angiotensin Receptor Blocker Synergistically Inhibits Heart Failure in Dahl-salt Sensitive Rats

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2007.06.297 ◽

2007 ◽

Vol 13 (6) ◽

pp. S63

Author(s):

Yasuhiro Maejima ◽

Susumu Adachi ◽

Hiroshi Ito ◽

Mitsuaki Isobe

Keyword(s):

Heart Failure ◽

Reductase Inhibitor ◽

Angiotensin Receptor Blocker ◽

Combined Treatment ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hmg Coa Reductase ◽